ReviewJCI insight2022
Targeting the undruggable oncogenic KRAS: the dawn of hope.
Hande Asimgil et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this papercites it
ReviewJCI insight2022
Hande Asimgil et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.